#United States #Alameda #Penumbra #Ruby XL #Embolization

Penumbra Unveils the Ruby® XL System

Penumbra, Inc., a prominent player in the medical technology field, has just announced its latest breakthrough: the Ruby® XL System. This innovative new device has received clearance from the U.S. Food and Drug Administration (FDA) and is set to transform the landscape of vascular embolization. Notable for being both the longest and softest coil available on the market, the Ruby XL System is engineered to maximize efficiency, minimize radiation exposure, and ultimately improve patient outcomes, particularly during high-flow and large vessel embolization procedures.

“We’ve engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings,” stated Shruthi Narayan, President of Interventional Business at Penumbra, Inc. This sentiment reflects Penumbra's commitment to harnessing innovation to meet the evolving needs of healthcare professionals and their patients. The Ruby XL System features three distinct technologies: Ruby XL, POD® XL, and Packing Coil XL. Each of these components is designed for seamless delivery through a 0.035" diagnostic catheter, thus ensuring procedural efficiency.

Features and Benefits

The Ruby XL coil boasts a primary diameter of .030" and can achieve sizes up to 40mm, with lengths of up to 70 cm available, allowing for a variety of clinical applications. The unique engineering of the Ruby XL coil incorporates a 3D complex shape that effectively frames aneurysms. This design is complemented by the POD XL, which features a hybrid, multistage approach utilizing three-in-one coil occlusion technology—this includes an anchoring segment, a framing segment, and a dense filling segment, making it ideal for high-flow vessels.

On the other hand, the Packing Coil XL embraces a highly innovative liquid metal wave shape technology, enabling it to adapt dynamically to the size of various vessels while maintaining its integrity across the extended lengths. Such advancements provide medical professionals with a range of options tailored to the demands of each specific case.

The launch of the Ruby XL System represents a significant enhancement in Penumbra's portfolio of peripheral embolization products. This expanded offering not only includes the advanced Ruby XL System but also guarantees that physicians have access to the latest coil technologies, ensuring they are equipped with the best tools to tackle complex medical conditions.

Penumbra's Commitment to Innovation

Penumbra, Inc. is recognized as a leader in thrombectomy technology, focusing on developing cutting-edge solutions for challenging medical conditions like ischemic stroke and venous thromboembolism. The company is committed to improving patient outcomes and the overall quality of life, boasting a diverse portfolio that includes the revolutionary computer-assisted vacuum thrombectomy system (CAVT™).

By delivering rapid, safe, and simple solutions for the removal of thrombi, Penumbra supports healthcare providers, hospitals, and clinics across over 100 countries. Its mission is underscored by a dedication to enhancing clinical outcomes and embracing the responsibility of innovating in effectively treating health concerns that can greatly impact lives.

For more details about the Ruby XL System and its capabilities, you can visit Penumbra’s website at www.penumbrainc.com/products/ruby-xl. The Ruby XL System not only underscores Penumbra’s innovation in the sector but marks a substantial leap forward in vascular embolization technology. As the company continues to evolve, it remains focused on pioneering advancements that address some of healthcare's most pressing challenges.

Important Safety Information

Potential users should be aware that federal law restricts the sale of these devices to or on the order of a physician. It’s essential to consult the complete instructions for use before utilization to understand product indications, contraindications, and any potential adverse events associated with it. For the complete Instructions for Use (IFU) summary, visit www.peninc.info/risk.

In conclusion, Penumbra’s Ruby XL System is a pivotal advancement in the field of vascular embolization, promising enhanced efficiency, cost-effectiveness, and improved patient care outcomes. This introduction is more than just a product launch; it's a testament to Penumbra’s focus on innovation and excellence in medical devices.